这项可行性随机对照试验将评估一项整合静观与运动的电子健康介入措施 eMindExCare 于香港接受积极治疗的前列腺癌患者中的可接受性、可行性及初步效果。参加者将按 1:1 比例随机分配至为期 8 周的 eMindExCare 介入组或加强健康教育注意力对照计划。
适应症：Prostate Cancer、Sleep Disturbance、Fatigue、Physical Inactivity、Pain
入组条件
纳入标准
- Diagnosed with prostate cancer, stage I, II, or III.
- Aged older than 18 years.
- Undergoing active treatment, including chemotherapy, radiotherapy, or hormone therapy, at Prince of Wales Hospital.
- Able to communicate and read Chinese.
- Has access to the Internet and a computer or tablet.
- Demonstrates clinically impaired sleep quality or insufficient physical activity as measured by ActiGraph. Clinically impaired sleep quality may include study-defined sleep disturbance criteria such as total sleep time less than 6.5 hours, sleep onset latency greater than 30 minutes, awakenings lasting greater than 5 minutes, or wake after sleep onset greater than 30 minutes.
排除标准
- Diagnosed with more than one primary cancer.
- Has metastatic disease.
- Has participated in a mindfulness programme.
- Is sufficiently physically active at the time of recruitment.
- Has a mental condition, World Health Organization/Eastern Cooperative Oncology Group performance status greater than 2, a physical disability that prevents participation in the intervention, or any other health problem that rules out regular physical activity as determined by the treating physician.
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。